Financial Advantage’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,000
Closed -$96K 38
2022
Q3
$96K Hold
1,000
0.09% 45
2022
Q2
$108K Sell
1,000
-100
-9% -$11.4K 0.1% 46
2022
Q1
$130K Hold
1,100
0.11% 46
2021
Q4
$154K Buy
1,100
+1,000
+1,000% +$128K 0.13% 41
2021
Q3
$11K Hold
100
0.01% 99
2021
Q2
$11K Hold
100
0.01% 100
2021
Q1
$11K Hold
100
0.01% 107
2020
Q4
$10K Hold
100
0.01% 99
2020
Q3
$10K Hold
100
0.01% 92
2020
Q2
$9K Hold
100
0.01% 126
2020
Q1
$7K Hold
100
0.01% 95
2019
Q4
$8K Hold
100
0.01% 92
2019
Q3
$8K Hold
100
0.01% 136
2019
Q2
$8K Hold
100
0.01% 91
2019
Q1
$7K Buy
+100
New +$7.44K 0.01% 95
2014
Q1
Sell
-1,290
Closed -$49K 132
2013
Q4
$49K Hold
1,290
0.04% 71
2013
Q3
$43K Buy
1,290
+90
+8% +$3.16K 0.04% 72
2013
Q2
$42K Buy
+1,200
New +$44K 0.04% 75

Other funds holding ABT

Financial Advantage's ABT Position: Q4 2022 in Review

Financial Advantage sold out of Abbott (ABT) in Q4 2022, closing a stake of 1,000 shares — an estimated $96K sold.

Financial Advantage first reported a position in ABT in Q2 2013 and held it in 18 quarters. The position peaked at $154K in Q4 2021. 2,764 funds tracked by Wall St. Rank hold ABT as of Q4 2022.

  • Financial Advantage reported no remaining Abbott position as of Q4 2022 after selling out during the quarter.
  • Financial Advantage sold 1,000 Abbott shares in Q4 2022, an estimated $96K.
  • Financial Advantage first reported a position in Abbott in Q2 2013 and held it in 18 quarters.
  • Financial Advantage's Abbott position peaked at $154K in Q4 2021.
  • 2,764 funds tracked by Wall St. Rank held Abbott as of Q4 2022.

Based on Financial Advantage's 13F filing for Q4 2022, filed 26 Jan 2023.